Inventor · disambiguated record
John Edward Connolly
Also filed as: CONNOLLY JOHN · CONNOLLY JOHN E · CONNOLLY John Edward
9 granted patents·9 pending applications·27 citations·filing 2005–2024
85Inventor score
Files withAGENCY SCIENCE TECH & RES10PARKER INST FOR CANCER IMMUNOTHERAPY4BAYLOR RES INST2TESSA THERAPEUTICS PTE LTD2
Top patents by PatentIndex Score
18 records- 0192US10472423B2IL2Rbeta/common gamma chain antibodiesAGENCY SCIENCE TECH & RES·Filed 2018·Granted Nov 12, 2019·7 cites·5 claims
- 0290US10696747B2IL2R common gamma chain antibodiesAGENCY SCIENCE TECH & RES·Filed 2018·Granted Jun 30, 2020·4 cites·5 claims
- 0389US12221469B2Switch receptors using IL-9 signaling domainsPARKER INST FOR CANCER IMMUNOTHERAPY·Filed 2023·Granted Feb 11, 2025·1 cites·20 claims
- 0488US10246512B2IL-2R beta/common gamma chain antibodiesAGENCY SCIENCE TECH & RES·Filed 2018·Granted Apr 2, 2019·6 cites·6 claims
- 0584US10167338B2Method of treating cancer using IL2R beta/common gamma chain antibodiesAGENCY SCIENCE TECH & RES·Filed 2016·Granted Jan 1, 2019·4 cites·2 claims
- 0682US10472421B2Method for expansion of a population of cells with IL2R beta/common gamma chain antibodiesAGENCY SCIENCE TECH & RES·Filed 2016·Granted Nov 12, 2019·3 cites·7 claims
- 0781US2025136664A1Switch receptors using il-9 signaling domainsPARKER INST FOR CANCER IMMUNOTHERAPY·Filed 2024·Application pending·0 cites
- 0880US2025179148A1Nucleic acids encoding switch receptors using il-9 receptor signaling domainsPARKER INST FOR CANCER IMMUNOTHERAPY·Filed 2024·Application pending·0 cites
- 0976US12202884B2Nucleic acids encoding switch receptors using IL-9 receptor signaling domainsPARKER INST FOR CANCER IMMUNOTHERAPY·Filed 2022·Granted Jan 21, 2025·0 cites·29 claims
- 1072US10342865B2Method for treating epstein-barr virus—positive cancer with immunotherapyAGENCY SCIENCE TECH & RES·Filed 2017·Granted Jul 9, 2019·2 cites·14 claims
- 1171US2024052046A1Il2rbeta/common gamma chain antibodiesAGENCY SCIENCE TECH & RES·Filed 2023·Application pending·0 cites
- 1264US11739157B2IL2Rbeta/common gamma chain antibodiesAGENCY SCIENCE TECH & RES·Filed 2018·Granted Aug 29, 2023·0 cites·15 claims
- 1351US2010061965A1Respiratory syncytial virus renders dendritic cells tolerogenicBAYLOR RES INST·Filed 2009·Application pending·0 cites
- 1447US2022340684A1Modified fc regionAGENCY SCIENCE TECH & RES·Filed 2019·Application pending·0 cites
- 1546US2019381167A1Method for treating epstein-barr virus - positive cancer with immunotherapyAGENCY SCIENCE TECH & RES·Filed 2019·Application pending·0 cites
- 1641US2006051358A1Immune response assessment methodBAYLOR RES INST·Filed 2005·Application pending·0 cites
- 1736US2019352373A1TGF-ß DECOY RECEPTORTESSA THERAPEUTICS PTE LTD·Filed 2018·Application pending·0 cites
- 1835US2019262397A1Chimeric antigen receptorTESSA THERAPEUTICS PTE LTD·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →